Skip to main content

The Effects of Isolated Proteinuria Detected After 20 Weeks of Pregnancy on Perinatal Outcomes

Abstract

Proteinuria is a component of preeclampsia, and the presence of proteinuria without an increase in blood pressure can precede preeclampsia. This study aims to investigate the perinatal effects of isolated proteinuria detected in a 24-h urine sample after the 20th week of pregnancy. This is a prospective study of the perinatal outcomes of 60 pregnancies without proteinuria and matched 58 pregnancies with isolated proteinuria in patients consecutively admitted to the department of obstetrics at a university hospital in Turkey. The pregnant patients with proteinuria and without proteinuria were statistically similar with respect to age, gravidity, parity and the number of living children on enrolment. There were no significant differences in terms of gestational age at enrolment, gestational age at delivery, or intrauterine growth restriction (IUGR) between patients with isolated proteinuria and patients without proteinuria. However, preeclampsia developed significantly more frequently in patients with isolated proteinuria (20.6% vs 6.6%, p = 0.048). There were no significant differences in terms of newborn weight, Apgar scores, need for the neonatal intensive care unit (NICU), or umbilical artery blood pH in patients with proteinuria and without proteinuria. Isolated proteinuria after 20 weeks of pregnancy does not appear to impair maternal or foetal outcomes. Identifying pregnant women with risk factors for preeclampsia, ensuring they attend meticulous follow-up schedules and performing their delivery at tertiary health care centres would help to improve maternal and foetal morbidity and prevent perinatal mortality.

This is a preview of subscription content, access via your institution.

References

  1. Villar J, Say L, Gulmezoglu AM, et al. Eclampsia and pre-eclampsia: a health problem for 2000 years. In: Critchly H, MacLean A, Poston L, Walker J, editors. Preeclampsia. London: RCOG Press; 2003. p. 189–207.

    Google Scholar 

  2. Ronsmans C, Graham WJ. On behalf of the Lancet Maternal Survival Series Steering Group. Maternal mortality: who, when, where, and why. Lancet. 2006;368:1189–200.

    Article  Google Scholar 

  3. Roberts CL, Ford JB, Algert CS, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open. 2011;1:e000101.

    Article  Google Scholar 

  4. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.

    Article  Google Scholar 

  5. Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016;387(10017):462–74.

    Article  Google Scholar 

  6. Akar ME, Eyi EG, Yilmaz ES, Yuksel B, Yilmaz Z. Maternal deaths and their causes in Ankara, Turkey, 1982–2001. J Health Popul Nutr. 2004;22(4):420–8.

    PubMed  Google Scholar 

  7. Koopmans CM, Bijlenga D, Groen H, Vijgen SMC, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–88.

    Article  Google Scholar 

  8. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the ACOG’s Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.

    Article  Google Scholar 

  9. Dubowitz LM, Dubowitz V, Goldberg C. Clinical assesment of gestational age in the newborn. J Pediatr. 1970;77:1–10.

    CAS  Article  Google Scholar 

  10. Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008;199:36.e1–5.

    Article  Google Scholar 

  11. Harmon QE, Huang L, Umbach DM, Klungsøyr K, Engel SM, Magnus P, et al. Risk of fetal death with preeclampsia. Obstet Gynecol. 2015;125(3):628–35.

    CAS  Article  Google Scholar 

  12. Cunningham FG, Leveno KJ, Bloom SL, et al. Hypertensive disorders of pregnancy. In:Willams Obstetrics. 24th ed. New York: McGraw-Hill; 2014. p. 728–80.

    Google Scholar 

  13. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22:203–12.

    Article  Google Scholar 

  14. Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Role of proteinuria in defining preeclampsia: clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2010;37(4):466–70.

    CAS  Article  Google Scholar 

  15. Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe pre-eclampsia. Am J Obstet Gynecol. 1996;175:1313–6.

    CAS  Article  Google Scholar 

  16. Maybury H, Waugh J. Proteinuria in pregnancy: just what is significant? Fetal Matern Med Rev. 2004;16:71–95.

    Article  Google Scholar 

  17. Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol. 1990;162:366–71.

    CAS  Article  Google Scholar 

  18. Lindheimer, Marshall D, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet Gynecol. 2010;115(2 Part 1):365–75.

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oğuz Özdemir.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Ethical Approval

The BEU Ethics Committee approved the study (2014-51-25/02).

Informed Consent

Taken from the patients.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Surgery

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Özdemir, O., Arıkan, İ.İ., Sel, G. et al. The Effects of Isolated Proteinuria Detected After 20 Weeks of Pregnancy on Perinatal Outcomes. SN Compr. Clin. Med. 2, 1661–1665 (2020). https://doi.org/10.1007/s42399-020-00419-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-020-00419-5

Keywords

  • Proteinuria
  • Pregnancy
  • Intrauterine growth restriction
  • Perinatal outcome